Personalis to Participate in BTIG 13th Annual MedTech Conference
ByAinvest
Wednesday, Jan 28, 2026 4:03 pm ET1min read
PSNL--
Personalis, a leader in advanced genomics for precision oncology, announced its participation in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The event will take place on February 11, 2026, at the Cliff Lodge in Snowbird, UT. Personalis aims to transform cancer management through personalized testing, guiding care from biopsy through the life of the patient. The company's products are designed to detect minimal residual disease and recurrence at early timepoints, enable targeted therapies, and enhance biomarker strategy for drug development.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet